Stay updated with breaking news from Tau Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $7.65 and traded as low as $7.61. Voyager Therapeutics shares last traded at $7.91, with a volume of 156,006 shares changing hands. Wall Street Analyst Weigh […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) CEO Alfred Sandrock sold 7,437 shares of the stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $7.83, for a total value of $58,231.71. Following the completion of the sale, the chief executive officer now directly owns 214,618 shares of […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) CEO Alfred Sandrock sold 7,437 shares of Voyager Therapeutics stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $7.83, for a total value of $58,231.71. Following the completion of the transaction, the chief executive officer now owns 214,618 shares of […]
Voyager Therapeutics (NASDAQ:VYGR – Get Rating) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Separately, Oppenheimer initiated coverage on shares of Voyager Therapeutics in a research report on Thursday, March 9th. They issued an “outperform” rating and a $14.00 price target for […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) COO Robin Swartz sold 3,654 shares of the business’s stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $7.76, for a total value of $28,355.04. Following the completion of the sale, the chief operating officer now directly owns […]